Boston Scientific Corp. (BSX)
46.84
+0.17
(+0.36%)
USD |
NYSE |
Aug 28, 16:00
46.84
0.00 (0.00%)
After-Hours: 20:00
Boston Scientific Free Cash Flow : 3.625B for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.625B |
| March 31, 2026 | 3.475B |
| December 31, 2025 | 3.658B |
| September 30, 2025 | 3.824B |
| June 30, 2025 | 3.485B |
| March 31, 2025 | 3.014B |
| December 31, 2024 | 2.645B |
| September 30, 2024 | 2.156B |
| June 30, 2024 | 1.841B |
| March 31, 2024 | 1.698B |
| December 31, 2023 | 1.792B |
| September 30, 2023 | 1.697B |
| June 30, 2023 | 1.51B |
| March 31, 2023 | 1.196B |
| December 31, 2022 | 938.00M |
| September 30, 2022 | 555.00M |
| June 30, 2022 | 594.00M |
| March 31, 2022 | 929.00M |
| December 31, 2021 | 1.317B |
| September 30, 2021 | 1.619B |
| June 30, 2021 | 1.853B |
| March 31, 2021 | 1.518B |
| December 31, 2020 | 1.132B |
| September 30, 2020 | 1.124B |
| June 30, 2020 | 911.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 911.00M |
| December 31, 2019 | 1.375B |
| September 30, 2019 | 782.00M |
| June 30, 2019 | 826.00M |
| March 31, 2019 | 148.00M |
| December 31, 2018 | -6.00M |
| September 30, 2018 | 874.00M |
| June 30, 2018 | 653.00M |
| March 31, 2018 | 1.238B |
| December 31, 2017 | 1.107B |
| September 30, 2017 | 613.00M |
| June 30, 2017 | 307.00M |
| March 31, 2017 | 542.00M |
| December 31, 2016 | 596.00M |
| September 30, 2016 | 541.00M |
| June 30, 2016 | 981.00M |
| March 31, 2016 | 652.00M |
| December 31, 2015 | 353.00M |
| September 30, 2015 | 470.00M |
| June 30, 2015 | 422.00M |
| March 31, 2015 | 628.00M |
| December 31, 2014 | 1.01B |
| September 30, 2014 | 838.00M |
| June 30, 2014 | 741.00M |
| March 31, 2014 | 866.00M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Abbott Laboratories | 7.824B |
| Becton, Dickinson & Co. | 2.533B |
| Penumbra, Inc. | 215.91M |
| Intuitive Surgical, Inc. | 3.223B |
| Stryker Corp. | 4.702B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.474B |
| Cash from Investing (Quarterly) | -1.956B |
| Cash from Financing (Quarterly) | -410.00M |
| Free Cash Flow Per Share (Quarterly) | 0.8672 |
| Free Cash Flow to Equity (Quarterly) | -316.00M |
| Free Cash Flow to Firm (Quarterly) | 1.368B |
| Free Cash Flow Yield | 5.19% |